Company news
Avenir Wellness Solutions Inc. (OTC:AVRW) news
Avenir Wellness Solutions Inc. news releases on 6ix. Latest, Apr 21, 2021: CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials…
Press releases — page 2
CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
April 21, 2021
CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT
April 19, 2021
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021
April 13, 2021
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020
April 1, 2021
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
March 23, 2021
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders
March 16, 2021
CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications
March 10, 2021
CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.
March 3, 2021
CURE Pharmaceutical Announces the Initiation of Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
February 23, 2021
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
February 11, 2021
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
February 10, 2021
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
February 2, 2021
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
January 19, 2021
CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
January 7, 2021
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
January 5, 2021
CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17
December 14, 2020
Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador
December 10, 2020
Nicole Kidman Partners With SeraLabs, a CURE Pharmaceutical Company, as a Strategic Business Partner and Global Brand Ambassador
December 8, 2020
CURE Pharmaceutical Issues Letter to Shareholders
November 18, 2020
CURE Pharmaceutical Closes $10 Million Financing
November 2, 2020
CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
October 29, 2020
CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company
September 24, 2020
CURE Pharmaceutical to Present at Two Virtual Events in September
September 2, 2020
Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, to be acquired by CURE Pharmaceutical in a $20 Million Transaction
July 30, 2020
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
July 28, 2020
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
July 8, 2020
CURE Pharmaceutical Appoints Chief Business Officer
June 16, 2020
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
June 9, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 3, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 21, 2020
CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction
March 17, 2020
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 12, 2020
UPDATE – CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 5, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 5, 2020
CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
December 5, 2019
CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors
November 19, 2019
CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension
November 14, 2019
CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
October 9, 2019
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
October 1, 2019
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
August 21, 2019
CURE Pharmaceutical Expands Board with Two Women Directors
August 7, 2019
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
July 24, 2019
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
June 19, 2019
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
May 30, 2019
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
May 22, 2019
CURE Pharmaceutical Expands Leadership Team with Key New Hires
May 20, 2019
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
May 14, 2019
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
May 2, 2019